CAMPBELL, CA – May 2, 2019 – Atia Vision, Inc., a Shifamed portfolio company committed to improving patient outcomes through the development of a modular presbyopia-correcting accommodating intraocular lens, announced today initial closing of its committed $20M Series D preferred stock financing. Financing was led by Cormorant Asset Management, with participation by The Capital Partnership (TCP), AMED Ventures and Shangbay Capital. The financing will be used to advance Atia Vision’s clinical efforts.
About Jenny BouasavanhThis author has not yet filled in any details.
So far Jenny Bouasavanh has created 2 blog entries.
Atia Vision Announces Upcoming Presentations Highlighting Modular Presbyopia-Correcting Intraocular Lens Technology
CAMPBELL, CA – September 11, 2019 – Atia Vision, Inc., a Shifamed portfolio company committed to improving patient outcomes through the development of a novel modular presbyopiacorrecting intraocular lens (IOL), today announced its technology will be featured in presentations at two ophthalmology conferences this week in Paris, France.